Merck to Acquire Pandion Therapeutics
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/19/2026
- Nasdaq climbs as chip and AI-linked stocks bounce back
- U.S. economy is "booming," JPMorgan’s Dimon says
- Musk pledges one share of SpaceX to every U.S. child
- Brent crude edges lower, even after Houthi attacks on Saudi infrastructure
- Prepare to buy the dip as U.S. stock selloff nears its end: Morgan Stanley
| Merck & Co. (NYSE: MRK) | Delayed: 143.63 -2.32 (1.59%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $145.95 | 52 Week High | $65.46 | |||
| Open | $145.00 | 52 Week Low | $47.97 | |||
| Day High | $147.41 | P/E | 97.71 | |||
| Day Low | $143.53 | EPS | $1.47 | |||
| Volume | 10,448,756 | |||||
| (NASDAQ: PAND) | Delayed: 60.05 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $60.05 | 52 Week High | $ | |||
| Open | $35.76 | 52 Week Low | $ | |||
| Day High | $60.05 | P/E | N/A | |||
| Day Low | $60.05 | EPS | $ | |||
| Volume | 1,360 | |||||
